OCTOBER 11, 2018 – THURSDAY
HALL A HALL B HALL C
09:00-10:00 Plenary Lecture: Liquid biopsy for cancer screening

 

 

Michael Neumaier

10:00-10:30 COFFEE BREAK 
10:30-12:00 S1. The role of clinical laboratories in diagnosis and manegement of cancer  Satellite Symposium  Satellite Symposium  
Epigenetics in cancer diagnostics. Current knowledge and future perspectives

 

 

Emin Kansu

The role of laboratory in determination and management of anticancer therapies

 

 

Aldo Tomasi

The impact of flow cytometry in clinical laboratory

 

 

Brent L. Wood

12:00-13:30 LUNCH & POSTER PRESENTATION
13:30-15:00 S2. Biomarkers of heart failure and prognosis S3. The utility of biomarkers in neurological disorders S10. WASPALM Symposia
The utility of high sensitive troponins in early diagnosis or rule out of AMI

 

 

Jordi Ordonez Llanos

Biomarkers of brain injury and neurodegenerative diseases

 

 

to be announced

Perspectives on women’s health care: Novel approaches for rare diseases, aging and cancer

 

 

Cinzia Marchese      

Prognostic markers of heart failure

 

 

Mehmet Birhan Yilmaz 

Cerebrospinal fluid biomarkers in diagnostics of neurodegenerative and inflammatory diseases

 

 

Kaj Blennow

Inositol metabolites as biomarkers of peripheral complications in insulin resistant and diabetes patients

 

 

Mariano Bizzarri    

The diagnosis and managemet of demantia

 

 

Sylvain Lehmann

Usefulness of intraoperative parathyroid hormone monitoring during minimally invasive video-assisted parathyroidectomy

 

 

Elisabetta Stenner

15:00-15:30 COFFEE BREAK
15:30-17:00 S5. Detecting kidney disease: From proteomics to the clinical laboratory

S22. Laboratory testing guideline in the intensive care unit    

S7. The rise and fall of total error concept in laboratory medicine
Proteomics for kidney diseases

 

 

to be announced

The role of laboratory medicine in intensive care unit

Ismail Cinel

Uncertainty or total allowable error: The big debate

 

 

Anders Kallner 

Urinary biomarkers in kidney transplantation: Application of Mass Spectrometry to measure peptides and proteins

 

 

Halide Akbas

Inflammation versus sepsis: Focus on biomarkers

Michael Meisner

From measurement to diagnosis: Uncertainty in laboratory medicine

 

 

Elvar Theodorsson

The clinical laboratory and kidney disease

 

 

Edmund J. Lamb

TDM of antibiotics

Paul M. Tulkens

Oral Presentations 
17:00-17:30 COFFEE BREAK 
17:30-18:30 S8. Endocrinologist and laboratorian, a friendship under construction S9. Personalized medicine S4. Diagnostic approach to hemostasis disorders
What do the endocrinologists expect from laboratory?

 

 

Ilhan Satman

The role of laboratory medicine in personalized and precision medicine

 

 

Mario Pazzagli       

Coagulation testing and new oral anticoagulants

 

 

Sophie Testa     

The role of laboratory in metabolic bone disease

 

 

Howard Morris

Personalized reference intervals

 

 

Yesim Ozarda

Biomarkers of hemostasis and thrombosis

 

 

Tilman Hacken

Diagnostic approach to hemostasis disorders

 

 

Hugo ten Cate